Granard Pharmaceuticals Sales & Marketing is Consulting Services (B2B) in United States that focus on marketing consulting programs business. Founded in 1997. They cover business area such as provider, pharmaceutical consulting service, customized sale, marketing consulting program, brand, -tech manufacturer.
1997
( 27 years old in 2024 )
Marketing Consulting Programs
-
Atlantic Corporate Center
2317 Highway 34
Manasquan, NJ 08736
United States
Private
providerpharmaceutical consulting servicecustomized salemarketing consulting programbrand-tech manufacturer
* We use standard office opening hours in near Granard Pharmaceuticals Sales & Marketing's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Granard Pharmaceuticals Sales & Marketing is Consulting Services (B2B) business from United States that founded in 1997 (27 years old in 2024), Granard Pharmaceuticals Sales & Marketing business is focusing on Marketing Consulting Programs.
Granard Pharmaceuticals Sales & Marketing headquarter office and corporate office address is located in Atlantic Corporate Center 2317 Highway 34 Manasquan, NJ 08736 United States.
Granard Pharmaceuticals Sales & Marketing was founded in United States.
In 2024, Granard Pharmaceuticals Sales & Marketing is currently focus on marketing consulting programs sector.
Above is snippet of Google Trends for "marketing consulting programs" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Granard Pharmaceuticals Sales & Marketing, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
